19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role of Fas and Treg Cells in Fracture Healing as Characterized in the Fas-Deficient (lpr) Mouse Model of Lupus†

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Previous studies showed that loss of tumor necrosis factor α (TNFα) signaling delayed fracture healing by delaying chondrocyte apoptosis and cartilage resorption. Mechanistic studies showed that TNFα induced Fas expression within chondrocytes; however, the degree to which chondrocyte apoptosis is mediated by TNFα alone or dependent on the induction of Fas is unclear. This question was addressed by assessing fracture healing in Fas-deficient B6.MRL/Fas lpr /J mice. Loss of Fas delayed cartilage resorption but also lowered bone fraction in the calluses. The reduced bone fraction was related to elevated rates of coupled bone turnover in the B6.MRL/Fas lpr /J calluses, as evidenced by higher osteoclast numbers and increased osteogenesis. Analysis of the apoptotic marker caspase 3 showed fewer positive chondrocytes and osteoclasts in calluses of B6.MRL/Fas lpr /J mice. To determine if an active autoimmune state contributed to increased bone turnover, the levels of activated T cells and Treg cells were assessed. B6.MRL/Fas lpr /J mice had elevated Treg cells in both spleens and bones of B6.MRL/Fas lpr /J but decreased percentage of activated T cells in bone tissues. Fracture led to ∼30% to 60% systemic increase in Treg cells in both wild-type and B6.MRL/Fas lpr /J bone tissues during the period of cartilage formation and resorption but either decreased (wild type) or left unchanged (B6.MRL/Fas lpr /J) the numbers of activated T cells in bone. These results show that an active autoimmune state is inhibited during the period of cartilage resorption and suggest that iTreg cells play a functional role in this process. These data show that loss of Fas activity specifically in chondrocytes prolonged the life span of chondrocytes and that Fas synergized with TNFα signaling to mediate chondrocyte apoptosis. Conversely, loss of Fas systemically led to increased osteoclast numbers during later periods of fracture healing and increased osteogenesis. These findings suggest that retention of viable chondrocytes locally inhibits osteoclast activity or matrix proteolysis during cartilage resorption. © 2014 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: not found
          • Article: not found

          Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

            Estrogen prevents osteoporotic bone loss by attenuating bone resorption; however, the molecular basis for this is unknown. Here, we report a critical role for the osteoclastic estrogen receptor alpha (ERalpha) in mediating estrogen-dependent bone maintenance in female mice. We selectively ablated ERalpha in differentiated osteoclasts (ERalpha(DeltaOc/DeltaOc)) and found that ERalpha(DeltaOc/DeltaOc) females, but not males, exhibited trabecular bone loss, similar to the osteoporotic bone phenotype in postmenopausal women. Further, we show that estrogen induced apoptosis and upregulation of Fas ligand (FasL) expression in osteoclasts of the trabecular bones of WT but not ERalpha(DeltaOc/DeltaOc) mice. The expression of ERalpha was also required for the induction of apoptosis by tamoxifen and estrogen in cultured osteoclasts. Our results support a model in which estrogen regulates the life span of mature osteoclasts via the induction of the Fas/FasL system, thereby providing an explanation for the osteoprotective function of estrogen as well as SERMs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

              Fas antigen is a cell-surface protein that mediates apoptosis. It is expressed in various tissues including the thymus and has structural homology with a number of cell-surface receptors, including tumour necrosis factor receptor and nerve growth factor receptor. Mice carrying the lymphoproliferation (lpr) mutation have defects in the Fas antigen gene. The lpr mice develop lymphadenopathy and suffer from a systemic lupus erythematosus-like autoimmune disease, indicating an important role for Fas antigen in the negative selection of autoreactive T cells in the thymus.
                Bookmark

                Author and article information

                Journal
                J Bone Miner Res
                J. Bone Miner. Res
                jbmr
                Journal of Bone and Mineral Research
                BlackWell Publishing Ltd (Oxford, UK )
                0884-0431
                1523-4681
                June 2014
                19 May 2014
                : 29
                : 6
                : 1478-1491
                Affiliations
                [1 ]Orthopaedic Research Laboratory, Boston University School of Medicine Boston, MA, USA
                [2 ]King Abdul Aziz University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery Jeddah, Saudi Arabia
                [3 ]Flow Cytometry Core Facility, Boston University School of Medicine Boston, MA, USA
                [4 ]University of Pennsylvania School of Dental Medicine Philadelphia, PA, USA
                [5 ]Department of Biomedical Engineering, Boston University School of Engineering Boston, MA, USA
                Author notes
                Address correspondence to: Louis C Gerstenfeld, PhD, Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Boston University School of Medicine E243, 72 East Concorde Street, Boston, MA 02118, USA. E-mail: lgersten@ 123456bu.edu
                [†]

                The copyright line in this article was changed on August 26, 2014 after original online publication.

                2014 American Society for Bone and Mineral Research

                Article
                10.1002/jbmr.2169
                4305200
                24677136
                eff3cc0b-8bbd-44e5-8570-02ac709ac43e
                © 2014 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research

                This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

                History
                : 20 July 2013
                : 10 December 2013
                : 28 December 2013
                Categories
                Original Articles

                Human biology
                chondrocytes,osteoclasts,fas,apoptosis,treg cells
                Human biology
                chondrocytes, osteoclasts, fas, apoptosis, treg cells

                Comments

                Comment on this article